|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
E-mail contact: wei-qin_zhao@northwestern.edu
Recent studies have indicated an association between Alzheimers disease (AD) and central nervous system (CNS) insulin resistance. However, the cellular mechanisms underlying the link between these two pathologies have not been elucidated. Here we show that signal transduction by neuronal insulin receptors (IR) is strikingly sensitive to disruption by soluble A
oligomers (also known as ADDLs). ADDLs are known to accumulate in AD brain and have recently been implicated as primary candidates for initiating deterioration of synapse function, composition, and structure. Using mature cultures of hippocampal neurons, a preferred model for studies of synaptic cell biology, we found that ADDLs caused a rapid and substantial loss of neuronal surface IRs specifically on dendrites bound by ADDLs. Removal of dendritic IRs was associated with increased receptor immunoreactivity in the cell body, indicating redistribution of the receptors. The neuronal response to insulin, measured by evoked IR tyrosine autophosphorylation, was greatly inhibited by ADDLs. Inhibition also was seen with added glutamate or potassium-induced depolarization. The effects on IR function were completely blocked by NMDA receptor antagonists, tetrodotoxin, and calcium chelator BAPTA-AM. Downstream from the IR, ADDLs induced a phosphorylation of Akt at serine473, a modification associated with neurodegenerative and insulin resistance diseases. These results identify novel factors that affect neuronal IR signaling and suggest that insulin resistance in AD brain is a response to ADDLs, which disrupt insulin signaling and may cause a brain-specific form of diabetes as part of an overall pathogenic impact on CNS synapses.—Zhao, W. Q., De Felice, F. G., Fernandez, S., Chen, H., Lambert, M. P., Quon, M. J., Krafft, G. A., Klein, W. L. Amyloid beta oligomers induce impairment of neuronal insulin receptors.
This article has been cited by other articles:
![]() |
W.-Q. Zhao, F. Santini, R. Breese, D. Ross, X. D. Zhang, D. J. Stone, M. Ferrer, M. Townsend, A. L. Wolfe, M. A. Seager, et al. Inhibition of Calcineurin-mediated Endocytosis and {alpha}-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptors Prevents Amyloid {beta} Oligomer-induced Synaptic Disruption J. Biol. Chem., March 5, 2010; 285(10): 7619 - 7632. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Fuentealba, Q. Liu, T. Kanekiyo, J. Zhang, and G. Bu Low Density Lipoprotein Receptor-related Protein 1 Promotes Anti-apoptotic Signaling in Neurons by Activating Akt Survival Pathway J. Biol. Chem., December 4, 2009; 284(49): 34045 - 34053. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Noguchi, S. Matsumura, M. Dezawa, M. Tada, M. Yanazawa, A. Ito, M. Akioka, S. Kikuchi, M. Sato, S. Ideno, et al. Isolation and Characterization of Patient-derived, Toxic, High Mass Amyloid {beta}-Protein (A{beta}) Assembly from Alzheimer Disease Brains J. Biol. Chem., November 20, 2009; 284(47): 32895 - 32905. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q.-L. Ma, F. Yang, E. R. Rosario, O. J. Ubeda, W. Beech, D. J. Gant, P. P. Chen, B. Hudspeth, C. Chen, Y. Zhao, et al. {beta}-Amyloid Oligomers Induce Phosphorylation of Tau and Inactivation of Insulin Receptor Substrate via c-Jun N-Terminal Kinase Signaling: Suppression by Omega-3 Fatty Acids and Curcumin J. Neurosci., July 15, 2009; 29(28): 9078 - 9089. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-Q. Zhao, P. N. Lacor, H. Chen, M. P. Lambert, M. J. Quon, G. A. Krafft, and W. L. Klein Insulin Receptor Dysfunction Impairs Cellular Clearance of Neurotoxic Oligomeric A{beta} J. Biol. Chem., July 10, 2009; 284(28): 18742 - 18753. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Q. Wang, Z. E. Floyd, J. Qin, X. Liu, Y. Yu, X. H. Zhang, J. D. Wagner, and W. T. Cefalu Modulation of Skeletal Muscle Insulin Signaling With Chronic Caloric Restriction in Cynomolgus Monkeys Diabetes, July 1, 2009; 58(7): 1488 - 1498. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Deshpande, H. Kawai, R. Metherate, C. G. Glabe, and J. Busciglio A Role for Synaptic Zinc in Activity-Dependent A{beta} Oligomer Formation and Accumulation at Excitatory Synapses J. Neurosci., April 1, 2009; 29(13): 4004 - 4015. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-K. Lee, P. Kumar, Q. Fu, K. M. Rosen, and H. W. Querfurth The Insulin/Akt Signaling Pathway Is Targeted by Intracellular {beta}-Amyloid Mol. Biol. Cell, March 1, 2009; 20(5): 1533 - 1544. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. G. De Felice, M. N. N. Vieira, T. R. Bomfim, H. Decker, P. T. Velasco, M. P. Lambert, K. L. Viola, W.-Q. Zhao, S. T. Ferreira, and W. L. Klein From the Cover: Protection of synapses against Alzheimer's-linked toxins: Insulin signaling prevents the pathogenic binding of A{beta} oligomers PNAS, February 10, 2009; 106(6): 1971 - 1976. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. J. Strachan, R. M. Reynolds, B. M. Frier, R. J. Mitchell, and J. F. Price The relationship between type 2 diabetes and dementia Br. Med. Bull., December 1, 2008; 88(1): 131 - 146. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Francis, J. A. Martinez, W. Q. Liu, K. Xu, A. Ayer, J. Fine, U. I. Tuor, G. Glazner, L. R. Hanson, W. H. Frey II, et al. Intranasal insulin prevents cognitive decline, cerebral atrophy and white matter changes in murine type I diabetic encephalopathy Brain, December 1, 2008; 131(12): 3311 - 3334. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. H. Varvel, K. Bhaskar, A. R. Patil, S. W. Pimplikar, K. Herrup, and B. T. Lamb A{beta} Oligomers Induce Neuronal Cell Cycle Events in Alzheimer's Disease J. Neurosci., October 22, 2008; 28(43): 10786 - 10793. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Beeri, J. Schmeidler, J. M. Silverman, S. Gandy, M. Wysocki, C. M. Hannigan, D. P. Purohit, G. Lesser, H. T. Grossman, and V. Haroutunian Insulin in combination with other diabetes medication is associated with less Alzheimer neuropathology Neurology, September 2, 2008; 71(10): 750 - 757. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. A. Gault and C. Holscher Protease-Resistant Glucose-Dependent Insulinotropic Polypeptide Agonists Facilitate Hippocampal LTP and Reverse the Impairment of LTP Induced by Beta-Amyloid J Neurophysiol, April 1, 2008; 99(4): 1590 - 1595. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |